Lupus vulgaris in an immunocompromised patient.
Departments of Medicine andPathology, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
Maisarah
M
Jalalonmuhali
Yin Y
YY
Lee
Chew K
CK
Lee
Rokiah
R
Ismail
Patricia A
PA
Chandran
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007538:Isoniazid / Q000627:therapeutic use; D016030:Kidney Transplantation; D008177:Lupus Vulgaris / Q000175:diagnosis* / Q000188:drug therapy*; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin